Effects of Okra on blood glucose of patients with diabetes mellitus type 2
Phase 3
- Conditions
- diabetes mellitus type 2.E11
- Registration Number
- IRCT20160310026998N8
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 128
Inclusion Criteria
All patients older than 18 years with diabetes mellitus type 2
who received oral agents (metformin/sulfonylureas/pioglitazone)
Exclusion Criteria
pregnancy and lactation
creatinine clearance less than 30 ml/min
severe hepatic impairment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduce the fasting blood sugar. Timepoint: At baseline and two months after intervention. Method of measurement: Blood sample analysis.;Hemoglobin a1c. Timepoint: At baseline and two months after intervention. Method of measurement: Blood sample analysis.
- Secondary Outcome Measures
Name Time Method Reduce of low density lipoprotein (LDL). Timepoint: At baseline and two months after intervention. Method of measurement: Blood sample analysis.;Weight loss. Timepoint: At baseline and two months after intervention. Method of measurement: scale.;Reduce triglycerides. Timepoint: At baseline and two months after intervention. Method of measurement: Blood sample analysis.